ClinConnect ClinConnect Logo
Search / Trial NCT02880098

Variations of High Sensitivity Troponin T in Neonates

Launched by HÔPITAL NOVO · Aug 25, 2016

Trial Information

Current as of July 03, 2025

Completed

Keywords

Neonatology Troponin T Standards

ClinConnect Summary

* Approximately 400 subjects will be recruited over a planned recruitment period of 2 months. During labour, or pre natal hospitalization, information about the study will be given to every mothers by the midwife or the pediatrician. Absence of opposition will be notified in the medical file.
* At birth, every child born alive is possibly eligible for this study, if he doesn't meet the exclusion criteria.
* After clamping the umbilical cord, the midwife realizes the systematic sample for assessment of pH and lactate. If the mother did not object to the study, the midwife will use 200µl of t...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Every newborn, born alive in René Dubos maternity, without regarding the way of birth.
  • Absence of malformative syndromes or genetic abnormalities in prenatal echographies
  • Absence of parental opposition
  • Exclusion Criteria:
  • Multiple pregnancies
  • Post natal discovery of malformative syndromes or genetic abnormality. All congenital heart diseases will be excluded.
  • Parental opposition at any time of the study

About Hôpital Novo

Hôpital Novo is a leading clinical trial sponsor dedicated to advancing medical research and improving patient outcomes through innovative studies and rigorous scientific methodologies. With a strong emphasis on collaboration and ethical practices, Hôpital Novo partners with healthcare professionals and institutions to conduct high-quality clinical trials across various therapeutic areas. Their commitment to patient safety, data integrity, and regulatory compliance ensures that all research initiatives are conducted to the highest standards, ultimately contributing to the development of new treatments and therapies that enhance healthcare delivery.

Locations

Pontoise, Val D'oise, France

Patients applied

0 patients applied

Trial Officials

BORRHOMEE Suzanne, PH

Principal Investigator

suzanne.borrhomee@gmail.com

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials